| Literature DB >> 21997190 |
J J Sandow1, A M Jabbour, M R Condina, C P Daunt, F C Stomski, B D Green, C D Riffkin, P Hoffmann, M A Guthridge, J Silke, A F Lopez, P G Ekert.
Abstract
P53-upregulated modifier of apoptosis (PUMA), a pro-apoptotic member of the Bcl-2 family, is transcriptionally activated by p53 and is a key effector of p53-dependent apoptosis. We show that PUMA protein is subject to rapid post-translational regulation by phosphorylation at a conserved residue, serine 10, following serum or interleukin-3 (IL-3) stimulation. Serine 10 is not within the Bcl-2 homology (BH3) domain, and PUMA phosphorylated at serine 10 retained the ability to co-immunoprecipitate with antiapoptotic Bcl-2 family members. However, phosphorylated PUMA was targeted for proteasomal degradation indicating that it is less stable than unphosphorylated PUMA. Importantly, we identified IKK1/IKK2/Nemo as the kinase complex that interacts with and phosphorylates PUMA, thereby also demonstrating that IL-3 activates NFκB signaling. The identification and characterization of this novel survival pathway has important implications for IL-3 signaling and hematopoietic cell development.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21997190 PMCID: PMC3307976 DOI: 10.1038/cdd.2011.131
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828